Show simple item record

dc.creatorJonathan L. Sessler
dc.creatorBrent L. Iverson
dc.creatorShaun P. Crofts
dc.creatorDarren Magda
dc.creatorPetra I. Sansom
dc.date.accessioned2019-10-23T21:40:17Z
dc.date.available2019-10-23T21:40:17Z
dc.date.issued1997-05-27
dc.identifier.urihttps://hdl.handle.net/2152/77202
dc.identifier.urihttp://dx.doi.org/10.26153/tsw/4291
dc.description.abstractThe invention is directed to a method of incorporating expanded porphyrins, and particularly of incorporating a sapphyrin or a texaphyrin, before, during, or after chemical synthesis of an oligomer to form an expanded porphyrin-oligonucleotide conjugate, and particularly a sapphyrin- or texaphyrin-oligonucleotide conjugate. This method includes reacting derivatized nucleotides and a sapphyrin or a texaphyrin in a desired order in an automated or manual DNA synthesizer having a solid support to form a sapphyrin- or a texaphyrin-oligonucleotide conjugate.
dc.publisherUnited States Patent and Trademark Office
dc.relation.ispartofUniversity of Texas Patents
dc.relation.ispartofUniversity of Texas Patents
dc.titlePhosphoramidite derivatives of texaphyrins
dc.typePatent
dc.description.departmentBoard of Regents, University of Texas System
dc.rights.restrictionOpen
dc.rights.restrictionOpen
dc.contributor.assigneePharmacyclics, Inc.
dc.contributor.assigneeBoard of Regents, The University of Texas System
dc.date.filed1996-03-13
dc.subject.cpcA61K47/546
dc.subject.cpcC07H21/00
dc.identifier.patentnumber5633354
dc.identifier.applicationnumber8614638
dc.subject.uspc534/15
dc.subject.uspc534/11
dc.subject.uspc534/13
dc.subject.uspc534/16
dc.subject.uspc536/17.1
dc.subject.uspc536/17.3
dc.subject.uspc536/17.4
dc.subject.uspc540/145
dc.subject.uspc540/465
dc.subject.uspc540/472


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record